Cargando…
A new intranasal therapy (MP29-02*) is more effective than current firstline therapy regardless of season, symptom or severity.
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493527/ http://dx.doi.org/10.1186/2045-7022-5-S4-P38 |
| _version_ | 1782379934433411072 |
|---|---|
| author | Bachert, Claus Fokkens, Wytske Hellings, Peter Scadding, Glenis Munzel, Ullrich Mullol, Joaquim |
| author_facet | Bachert, Claus Fokkens, Wytske Hellings, Peter Scadding, Glenis Munzel, Ullrich Mullol, Joaquim |
| author_sort | Bachert, Claus |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4493527 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-44935272015-07-15 A new intranasal therapy (MP29-02*) is more effective than current firstline therapy regardless of season, symptom or severity. Bachert, Claus Fokkens, Wytske Hellings, Peter Scadding, Glenis Munzel, Ullrich Mullol, Joaquim Clin Transl Allergy Poster Presentation BioMed Central 2015-06-26 /pmc/articles/PMC4493527/ http://dx.doi.org/10.1186/2045-7022-5-S4-P38 Text en Copyright © 2015 Bachert et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Bachert, Claus Fokkens, Wytske Hellings, Peter Scadding, Glenis Munzel, Ullrich Mullol, Joaquim A new intranasal therapy (MP29-02*) is more effective than current firstline therapy regardless of season, symptom or severity. |
| title | A new intranasal therapy (MP29-02*) is more effective than current firstline therapy regardless of season, symptom or severity. |
| title_full | A new intranasal therapy (MP29-02*) is more effective than current firstline therapy regardless of season, symptom or severity. |
| title_fullStr | A new intranasal therapy (MP29-02*) is more effective than current firstline therapy regardless of season, symptom or severity. |
| title_full_unstemmed | A new intranasal therapy (MP29-02*) is more effective than current firstline therapy regardless of season, symptom or severity. |
| title_short | A new intranasal therapy (MP29-02*) is more effective than current firstline therapy regardless of season, symptom or severity. |
| title_sort | new intranasal therapy (mp29-02*) is more effective than current firstline therapy regardless of season, symptom or severity. |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493527/ http://dx.doi.org/10.1186/2045-7022-5-S4-P38 |
| work_keys_str_mv | AT bachertclaus anewintranasaltherapymp2902ismoreeffectivethancurrentfirstlinetherapyregardlessofseasonsymptomorseverity AT fokkenswytske anewintranasaltherapymp2902ismoreeffectivethancurrentfirstlinetherapyregardlessofseasonsymptomorseverity AT hellingspeter anewintranasaltherapymp2902ismoreeffectivethancurrentfirstlinetherapyregardlessofseasonsymptomorseverity AT scaddingglenis anewintranasaltherapymp2902ismoreeffectivethancurrentfirstlinetherapyregardlessofseasonsymptomorseverity AT munzelullrich anewintranasaltherapymp2902ismoreeffectivethancurrentfirstlinetherapyregardlessofseasonsymptomorseverity AT mulloljoaquim anewintranasaltherapymp2902ismoreeffectivethancurrentfirstlinetherapyregardlessofseasonsymptomorseverity AT bachertclaus newintranasaltherapymp2902ismoreeffectivethancurrentfirstlinetherapyregardlessofseasonsymptomorseverity AT fokkenswytske newintranasaltherapymp2902ismoreeffectivethancurrentfirstlinetherapyregardlessofseasonsymptomorseverity AT hellingspeter newintranasaltherapymp2902ismoreeffectivethancurrentfirstlinetherapyregardlessofseasonsymptomorseverity AT scaddingglenis newintranasaltherapymp2902ismoreeffectivethancurrentfirstlinetherapyregardlessofseasonsymptomorseverity AT munzelullrich newintranasaltherapymp2902ismoreeffectivethancurrentfirstlinetherapyregardlessofseasonsymptomorseverity AT mulloljoaquim newintranasaltherapymp2902ismoreeffectivethancurrentfirstlinetherapyregardlessofseasonsymptomorseverity |